Gallant Pet

31/10/2025

🐾 Black cats are Halloween staples, gracing costumes, cards, and candy wrappers. But beyond the fun, there’s a less charming truth: they’re often overlooked in shelters.

This Halloween, we’re exploring the history behind the superstition, and why it still affects adoption rates today. At Gallant, we believe understanding leads to empathy, and empathy drives better care.

Let’s replace myth with knowledge, and give every pet the future they deserve.
📖 Read the blog: https://www.gallant.com/blog/why-are-people-so-weird-about-black-cats

07/10/2025

🧬 New board, new momentum.

Gallant is proud to welcome Dr. Misti Ushio and Doug Drew to our Board of Directors, bringing deep expertise from across human and animal health as we prepare to deliver what could become the first FDA-approved, ready-to-use stem cell therapy for pets.

Dr. Ushio has built category-defining biotech companies from the bench to the market.

Doug Drew has shaped veterinary care at scale, leading over 3,000 clinics worldwide.

Their leadership comes at a pivotal time as Gallant moves from development to delivery, with a therapy designed to target disease at its source, not just the symptoms.

📰 Full announcement:https://bit.ly/46MkX8U

/PRNewswire/ -- Gallant, an animal health biotechnology company pioneering ready-to-use stem cell therapies for pets, today announced the addition of Misti...

15/08/2025

📞 The is real!

16/07/2025

Just finished a 6-hour nap to recover from my 3-hour nap.
No meds, no surgery, just vibes. 😼💤

15/07/2025

Gallant Explains: Are allogeneic stem cells immune‑privileged?

Our latest blog breaks down the science behind how these cells may help avoid immune rejection, and why that matters in the development of ready‑to‑use regenerative therapies for pets.

📖 Read the full blog post: https://bit.ly/4kIWVAK

Allogeneic mesenchymal stem cells are often described as immune-privileged—but what does that mean? Learn how low MHC expression helps MSCs modulate immunity and why immune responses vary by patient and environment.

10/07/2025

🚗💨 Commute: check
☕ Coffee: double check
🧪 Lab coat: buttoned
💉 Cells: still stemmin’

Just another day making science real as Biomanufacturing Associate—where the science is serious, but the vibes are not.

01/07/2025

Big news: Gallant has closed an $18M Series B to bring our stem cell therapies one step closer to veterinary clinics.

Led by Digitalis Ventures, new investment from NovaQuest,and ongoing support from BOLD Capital, and Hill Creek Partners, this funding supports our mission to develop ready-to-use stem cell therapiesthat fit seamlessly into everyday veterinary care—starting with a product for cats with refractory FCGS.

We’re building a new category of care that supports the body’s natural repair process and helps pets live healthier, more joyful lives.

Read the full press release here: https://bit.ly/3I8hYiy

30/06/2025

We’ve rebranded—and it’s more than a new look. It’s a renewed expression of our mission.💜

At Gallant, we’re building a future where regenerative medicine is part of everyday veterinary care, designed to reduce inflammation and support the body’s natural healing process. Built for everyday veterinary use, grounded in science, and driven by compassion.

Our updated identity reflects the truth we’ve always believed: pets deserve more than symptom management;they deserve care that helps restore health at the source, because when pets thrive, the people who love them do too.

To the brilliant minds, open hearts, and steady hands who helped shape this evolution, thank you.

Welcome to the new Gallant 🙂 www.gallant.com

25/06/2025

🧪 Do you know how stem cells work?

They’re more than just cells—they’re central to how we’re redefining care in veterinary medicine. At Gallant, we’re studying how standardized, off-the-shelf stem cells could one day fit seamlessly into everyday vet care.

Tap to learn more and follow the science.